Thus, we can speculate that, at least for CC2D1A and SYTL5, the effects observed are not due to cytotoxicity, as membrane integrity is preserved, and these hits can be further tested as candidate therapeutic modulators in synucleinopathies. Here, CC2D1A is linked to synucleinopathy.